{"id":"https://openalex.org/W2416251908","doi":null,"title":"[Alemtuzumab in chronic lymphocytic leukemia treatment: retrospective analysis of outcome according to cytogenetics].","display_name":"[Alemtuzumab in chronic lymphocytic leukemia treatment: retrospective analysis of outcome according to cytogenetics].","publication_year":2009,"publication_date":"2009-06-01","ids":{"openalex":"https://openalex.org/W2416251908","mag":"2416251908","pmid":"https://pubmed.ncbi.nlm.nih.gov/19662885"},"language":"cs","primary_location":{"id":"pmid:19662885","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19662885","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vnitrni lekarstvi","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042672780","display_name":"Michael Doubek","orcid":"https://orcid.org/0000-0002-1269-6282","observed_orcids":["https://orcid.org/0000-0002-1269-6282"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Doubek","raw_affiliation_strings":["Intern\u00ed hematoonkologic\u00e1 klinika L\u00e9karsk\u00e9 fakulty MU a FN Brno. mdoubek@fnbrno.cz","Intern\u00ed hematoonkologic\u00e1 klinika L\u00e9karsk\u00e9 fakulty MU a FN Brno"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intern\u00ed hematoonkologic\u00e1 klinika L\u00e9karsk\u00e9 fakulty MU a FN Brno. mdoubek@fnbrno.cz","institution_ids":[]},{"raw_affiliation_string":"Intern\u00ed hematoonkologic\u00e1 klinika L\u00e9karsk\u00e9 fakulty MU a FN Brno","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080907370","display_name":"Alexandra Jungov\u00e1","orcid":"https://orcid.org/0000-0003-3056-3130","observed_orcids":["https://orcid.org/0000-0003-3056-3130"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Jungov\u00e1","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050677270","display_name":"Martin Brejcha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Brejcha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049999011","display_name":"Anna Panovsk\u00e1","orcid":"https://orcid.org/0000-0003-4955-3039","observed_orcids":["https://orcid.org/0000-0003-4955-3039"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Panovsk\u00e1","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065520471","display_name":"Yvona Brychtov\u00e1","orcid":"https://orcid.org/0000-0003-1038-870X","observed_orcids":["https://orcid.org/0000-0003-1038-870X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Brychtov\u00e1","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076375602","display_name":"Zden\u011bk Posp\u0131\u0301\u0161il","orcid":"https://orcid.org/0000-0001-6182-3068","observed_orcids":["https://orcid.org/0000-0001-6182-3068"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z Posp\u00edsil","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054654885","display_name":"Ji\u0159\u0131\u0301 Mayer","orcid":"https://orcid.org/0000-0003-0567-9887","observed_orcids":["https://orcid.org/0000-0003-0567-9887"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Mayer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.33026986,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"55","issue":"6","first_page":"549","last_page":"54"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alemtuzumab","display_name":"alemtuzumab","score":1.0},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/b-cell-cll","display_name":"B-cell CLL","score":0.7480000257492065},{"id":"https://openalex.org/keywords/chromosomal-abnormalities","display_name":"chromosomal abnormalities","score":0.8420000076293945},{"id":"https://openalex.org/keywords/17p-deletion","display_name":"17p deletion","score":0.9729999899864197},{"id":"https://openalex.org/keywords/11q-deletion","display_name":"11q deletion","score":0.8980000019073486},{"id":"https://openalex.org/keywords/13q-deletion","display_name":"13q deletion","score":0.9869999885559082},{"id":"https://openalex.org/keywords/trisomy-12","display_name":"trisomy 12","score":0.9909999966621399},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8920000195503235},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9440000057220459},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.5199999809265137},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.578000009059906}],"concepts":[{"id":"https://openalex.org/C2779015954","wikidata":"https://www.wikidata.org/wiki/Q420164","display_name":"Alemtuzumab","level":3,"score":0.9696381092071533},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.8055559992790222},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.701311469078064},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.6731433868408203},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.654205322265625},{"id":"https://openalex.org/C174475383","wikidata":"https://www.wikidata.org/wiki/Q246128","display_name":"Cytogenetics","level":4,"score":0.5537374019622803},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48372605443000793},{"id":"https://openalex.org/C2776229224","wikidata":"https://www.wikidata.org/wiki/Q844903","display_name":"Trisomy","level":2,"score":0.47752586007118225},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4721258580684662},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4697321653366089},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.4286797046661377},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38283613324165344},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3568668067455292},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.2162451446056366},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15518617630004883},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.12465542554855347},{"id":"https://openalex.org/C30481170","wikidata":"https://www.wikidata.org/wiki/Q37748","display_name":"Chromosome","level":3,"score":0.06536144018173218},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000074323","descriptor_name":"Alemtuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000912","descriptor_name":"Antibodies, Neoplasm","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000912","descriptor_name":"Antibodies, Neoplasm","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:19662885","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19662885","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vnitrni lekarstvi","raw_type":"Journal Article"},{"id":"mag:2416251908","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19662885","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2991660930","https://openalex.org/W2137334420","https://openalex.org/W2032423071","https://openalex.org/W2562063355","https://openalex.org/W2148329145","https://openalex.org/W2015856099","https://openalex.org/W2478115498","https://openalex.org/W6962477800","https://openalex.org/W2026007874","https://openalex.org/W2102885432"],"abstract_inverted_index":{"UNLABELLED:":[0],"Alemtuzumab":[1,15,137],"in":[2,18,42,102,132,153],"chronic":[3,20],"lymphocytic":[4,21],"leukemia":[5,22],"treatment:":[6],"retrospective":[7,34],"analysis":[8],"of":[9,39,63,70,87,108,156],"outcome":[10],"according":[11],"to":[12,30,119],"cytogenetics":[13],"SUMMARY:":[14],"is":[16],"effective":[17,139],"B-cell":[19],"(CLL)":[23],"with":[24,45],"17p":[25,83],"deletion,":[26,78,84],"which":[27],"responds":[28],"poorly":[29],"chemotherapeutic":[31],"agents.":[32],"Our":[33],"study":[35],"evaluated":[36],"the":[37,103,133,154],"benefit":[38],"alemtuzumab":[40,109],"monotherapy":[41],"unselected":[43],"patients":[44],"advanced":[46],"CLL,":[47],"categorized":[48],"by":[49],"cytogenetic":[50,71,142],"profile.":[51],"Data":[52],"were":[53,146],"collected":[54],"from":[55],"74":[56],"consecutive":[57],"who":[58],"had":[59],"received":[60],"alemtuzumab.":[61],"Median":[62],"previous":[64],"therapies":[65],"was":[66,94,114,122,129,138],"2.":[67],"The":[68,90],"incidence":[69],"abnormalities":[72],"was:":[73],"trisomy":[74],"12,":[75],"10%;":[76],"13q":[77],"13%;":[79],"11q":[80],"deletion":[81],"25%;":[82],"26%;":[85],"none":[86],"these,":[88],"26%.":[89],"overall":[91,127],"response":[92],"rate":[93],"65%":[95],"(11%":[96],"complete":[97],"remission,":[98],"54%":[99],"partial":[100],"remission)":[101],"whole":[104],"cohort.":[105],"From":[106],"start":[107],"therapy,":[110],"median":[111,117,126],"progression-free":[112],"survival":[113,128],"217":[115],"days,":[116,124],"time":[118],"alternative":[120],"treatment":[121],"287":[123],"and":[125],"999":[130],"days":[131],"total":[134],"cohort,":[135],"respectively.":[136],"across":[140],"all":[141],"categories":[143],"evaluated.":[144],"There":[145],"no":[147],"statistically":[148],"significant":[149],"differences":[150],"between":[151],"subgroups":[152],"level":[155],"efficacy.":[157]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}